Biomarker Technologies Integrates Multi-Omics for Biotechnology Advancements

Biomarker Technologies (BMKGene) is advancing the field of biotechnology by integrating multi-omics approaches. The company combines diverse molecular data, including genomics, transcriptomics, and proteomics, to achieve a deeper understanding of biological systems. The goal is to move from basic research to practical applications in areas such as synthetic biology, biomanufacturing, and precision medicine.

Addressing complex biological questions, such as identifying the reasons behind altered production performance in engineered strains or instability in bioprocesses, often requires examining multiple molecular layers rather than relying on a single data source. BMKGene provides tools to tackle these challenges. Their approach includes whole-genome sequencing (WGS) to identify genetic variations, RNA sequencing and proteomics to analyze gene expression and protein changes, and metabolomics to pinpoint metabolic bottlenecks.

The company emphasizes that the appropriate "omics" strategy depends on the specific biological question. For instance, when an engineered microbial strain experiences reduced performance, WGS can identify accumulated genetic mutations, while RNA-seq and proteomics can reveal changes in stress responses or metabolism. For analyzing unstable wastewater treatment processes, metagenomics helps characterize microbial community composition, metatranscriptomics provides insights into functional activity, and metabolomics reveals changes in metabolic output.

BMKGene's services have also been applied to study newly discovered microorganisms with valuable compound production capabilities. Their methods enable precise taxonomic identification and mapping of genetic potential, potentially leading to the development of novel bioprocesses. The company cites publications where its multi-omics services have supported microbial engineering and the valorization of biomass waste into valuable products.